486 related articles for article (PubMed ID: 16978367)
1. Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a meta-analysis of randomized double-blind controlled trials.
Song Y; He K; Levitan EB; Manson JE; Liu S
Diabet Med; 2006 Oct; 23(10):1050-6. PubMed ID: 16978367
[TBL] [Abstract][Full Text] [Related]
2. Effect of oral magnesium supplementation on the lipid profile and blood glucose of patients with type 2 diabetes mellitus.
Lal J; Vasudev K; Kela AK; Jain SK
J Assoc Physicians India; 2003 Jan; 51():37-42. PubMed ID: 12693452
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.
Hermansen K; Kipnes M; Luo E; Fanurik D; Khatami H; Stein P;
Diabetes Obes Metab; 2007 Sep; 9(5):733-45. PubMed ID: 17593236
[TBL] [Abstract][Full Text] [Related]
4. Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and beta-cell function in patients with type 2 diabetes.
Brazg R; Xu L; Dalla Man C; Cobelli C; Thomas K; Stein PP
Diabetes Obes Metab; 2007 Mar; 9(2):186-93. PubMed ID: 17300594
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
Rosenstock J; Brazg R; Andryuk PJ; Lu K; Stein P;
Clin Ther; 2006 Oct; 28(10):1556-68. PubMed ID: 17157112
[TBL] [Abstract][Full Text] [Related]
6. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
Wenying Y; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Ligthelm R; Valensi P;
Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116
[TBL] [Abstract][Full Text] [Related]
7. Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone.
Derosa G; D'Angelo A; Salvadeo SA; Ferrari I; Gravina A; Fogari E; Maffioli P; Cicero AF
Metabolism; 2008 Nov; 57(11):1552-7. PubMed ID: 18940393
[TBL] [Abstract][Full Text] [Related]
8. Oral magnesium supplementation in insulin-requiring Type 2 diabetic patients.
de Valk HW; Verkaaik R; van Rijn HJ; Geerdink RA; Struyvenberg A
Diabet Med; 1998 Jun; 15(6):503-7. PubMed ID: 9632126
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of glargine compared with NPH insulin for the treatment of Type 2 diabetes: a meta-analysis of randomized controlled trials.
Bazzano LA; Lee LJ; Shi L; Reynolds K; Jackson JA; Fonseca V
Diabet Med; 2008 Aug; 25(8):924-32. PubMed ID: 18959605
[TBL] [Abstract][Full Text] [Related]
10. Addition of thiazolidinedione or exenatide to oral agents in type 2 diabetes: a meta-analysis.
Pinelli NR; Cha R; Brown MB; Jaber LA
Ann Pharmacother; 2008 Nov; 42(11):1541-51. PubMed ID: 18957626
[TBL] [Abstract][Full Text] [Related]
11. The impact of vitamin and/or mineral supplementation on lipid profiles in type 2 diabetes.
Farvid MS; Siassi F; Jalali M; Hosseini M; Saadat N
Diabetes Res Clin Pract; 2004 Jul; 65(1):21-8. PubMed ID: 15163474
[TBL] [Abstract][Full Text] [Related]
12. Effect of oral L-arginine supplementation on blood pressure: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Dong JY; Qin LQ; Zhang Z; Zhao Y; Wang J; Arigoni F; Zhang W
Am Heart J; 2011 Dec; 162(6):959-65. PubMed ID: 22137067
[TBL] [Abstract][Full Text] [Related]
13. Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study.
Schwartz SL; Ratner RE; Kim DD; Qu Y; Fechner LL; Lenox SM; Holcombe JH
Clin Ther; 2008 May; 30(5):858-67. PubMed ID: 18555933
[TBL] [Abstract][Full Text] [Related]
14. Effects of rosuvastatin on lipids, lipoproteins and apolipoproteins in the dyslipidaemia of diabetes.
Betteridge DJ; Gibson JM
Diabet Med; 2007 May; 24(5):541-9. PubMed ID: 17367312
[TBL] [Abstract][Full Text] [Related]
15. An intensified lifestyle intervention programme may be superior to insulin treatment in poorly controlled Type 2 diabetic patients on oral hypoglycaemic agents: results of a feasibility study.
Aas AM; Bergstad I; Thorsby PM; Johannesen O; Solberg M; Birkeland KI
Diabet Med; 2005 Mar; 22(3):316-22. PubMed ID: 15717881
[TBL] [Abstract][Full Text] [Related]
16. Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials.
Nordmann AJ; Nordmann A; Briel M; Keller U; Yancy WS; Brehm BJ; Bucher HC
Arch Intern Med; 2006 Feb; 166(3):285-93. PubMed ID: 16476868
[TBL] [Abstract][Full Text] [Related]
17. The influence of chromium chloride-containing milk to glycemic control of patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial.
Pei D; Hsieh CH; Hung YJ; Li JC; Lee CH; Kuo SW
Metabolism; 2006 Jul; 55(7):923-7. PubMed ID: 16784965
[TBL] [Abstract][Full Text] [Related]
18. Almonds have a neutral effect on serum lipid profiles: a meta-analysis of randomized trials.
Phung OJ; Makanji SS; White CM; Coleman CI
J Am Diet Assoc; 2009 May; 109(5):865-73. PubMed ID: 19394473
[TBL] [Abstract][Full Text] [Related]
19. Effect of cranberry extracts on lipid profiles in subjects with Type 2 diabetes.
Lee IT; Chan YC; Lin CW; Lee WJ; Sheu WH
Diabet Med; 2008 Dec; 25(12):1473-7. PubMed ID: 19046248
[TBL] [Abstract][Full Text] [Related]
20. Magnesium prophylaxis for arrhythmias after cardiac surgery: a meta-analysis of randomized controlled trials.
Shiga T; Wajima Z; Inoue T; Ogawa R
Am J Med; 2004 Sep; 117(5):325-33. PubMed ID: 15336582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]